(Q84885912)
Statements
Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia (English)
Ester M Orlandi
Barbara Rocca
3 September 2011
scientific article published on 03 September 2011